A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

Phase 0 Completed 12 enrolled Novo Nordisk A/S

RandomizedCrossoverOpen-labelOther

Summary

In this study biomarkers in the blood after exposure to heparin in the fasted state or after a high-fat meal will be investigated. Heparin will be administered as an intravenous (iv) injection (injection directly in a blood vessel). In this study, the effects of administration of heparin will be compared with the effects of administration of normal saline which will also be administered as an iv injection.

Timeline

Start: 2021-12-17
Primary completion: 2022-01-11
Completion: 2022-01-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Heparin	Other / unclassified	25 iu/kg	Intravenous
Subject	Heparin	Other / unclassified	50 iu/kg	Intravenous

Indications

No indication recorded.